A white paper from NPC and Discern Health analyzes the landscape of available patient-reported measures and patient-reported performance measures in oncology, and offers recommendations for filling gaps in measures and removing barriers to measure implementation in accountable care programs.

Join AcademyHealth and NPC for an interactive webinar on June 18 at 2 p.m. ET to understand the underlying differences in health care spending estimates from various sources and learn how to address them to set the stage for a collaborative and evidence-based policy discussion.

In his latest column for Specialty Pharmacy Times, NPC President and CEO Dan Leonard explores recent research that found biopharmaceuticals provide substantial health care benefits at modest cost for six of the top seven conditions causing death and mortality between 1995 and 2005, providing powerful proof with which to challenge the conventional wisdom that all health care spending is out of control.